MARKET

EBS

EBS

Emergent Biosolutions Inc
NYSE
4.840
-0.470
-8.85%
After Hours: 4.831 -0.009 -0.19% 19:56 08/07 EDT
OPEN
5.40
PREV CLOSE
5.31
HIGH
5.55
LOW
4.810
VOLUME
3.14M
TURNOVER
--
52 WEEK HIGH
14.06
52 WEEK LOW
4.810
MARKET CAP
248.29M
P/E (TTM)
-20.2680
1D
5D
1M
3M
1Y
5Y
1D
Weekly Buzz: MRNA, NVS, SNY Gain Approvals; EBS, LSTA Cut Jobs; TARS, BIVI Drive Deals & Data
NASDAQ · 9h ago
U.S. CDC Says As Of August 6, 2,465 Confirmed Measles Cases Were Reported In U.S. In 2026; There Have Been 38 New Measles Outbreaks Reported In 2026, And 94% Of Confirmed Cases Are Outbreak-Associated
Benzinga · 9h ago
Trump Trade: U.S. issues 15% duty on products made from polysilicon
TipRanks · 10h ago
Trump admin plans to issue executive order on vaccines, autism, Bloomberg says
TipRanks · 14h ago
Emergent BioSolutions Q2 Revenue Jumps, Net Loss Widens Amid Restructuring
NASDAQ · 15h ago
Emergent BioSolutions is Now Oversold (EBS)
NASDAQ · 1d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 1d ago
Emergent Bio slips despite Q2 beat amid cost-cutting plan
Seeking Alpha · 1d ago
More
About EBS
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.

Webull offers Emergent Biosolutions Inc stock information, including NYSE: EBS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EBS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EBS stock methods without spending real money on the virtual paper trading platform.